COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > Oatzempic

<< Previous

Bullboard Posts

Comment by Hopeforthebeston Jan 11, 2025 11:53am

53 Views

Post# 36399415

RE:Oatzempic

Archeo, if you are relying on gagnon to actually deliver something think again. If there is one consistency with gagnon, actuallly 2 (failure being NO 1) no 2 is his ability to never have been able to deliver on his promises come agm time. He has never and will never be able to deliver because is is incompentent, will say anything to maintain his style of living, and frankly he has no regard for the shareholder. JUST ASK OATS. Merger of equals, my donkey.

<< Previous

Bullboard Posts

Market Open: Futures Fall Tailing Strong US Job Reports